Chemotherapy is indicated for high risk melanomas (stages IIB-IV) as adjuvant therapy and for metastatic disease as first-line therapy. Several single agent and combination regimens have been studied, all with modest impact on survival. All current guidelines still recommend enrollment in clinical trials over current available regimens for patients with metastatic disease. Interferon therapy is the only regimen recommended for adjuvant therapy.
Melanoma medical therapy
Melanoma surgery
Skin cancer surgery
Kaposi's sarcoma surgery
Radiation injury medical therapy
Prostate cancer medical therapy
Linitis plastica medical therapy
Oral cancer medical therapy